Charles Schwab Investment Management Inc Wave Life Sciences Ltd. Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 914,469 shares of WVE stock, worth $9.67 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
914,469
Previous 844,617
8.27%
Holding current value
$9.67 Million
Previous $6.93 Million
63.34%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding WVE
# of Institutions
192Shares Held
122MCall Options Held
430KPut Options Held
330K-
Ra Capital Management, L.P. Boston, MA18.2MShares$192 Million3.65% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.62MShares$102 Million0.22% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx8.26MShares$87.3 Million1.98% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$71.2 Million0.0% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.71MShares$71 Million0.81% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $918M
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...